🚀 The AI-SaaS Gambit: Decoding the Capillary Technologies IPO

An Initial Public Offering (IPO) is like a startup’s graduation ceremony. After years of hard work, private funding, and quiet growth, they’re finally stepping onto the public stage, asking you, the individual investor, to buy a piece of their future Capillary Technologies IPO Day 2

Also Read

NCERT Objection Key 2026: Complete Guide to Raise Objections, Dates, Fees & Process

Capillary Technologies is an interesting student in this graduating class. They aren’t selling cement or steel; they are selling loyalty. Specifically, they offer AI-based, cloud-native SaaS solutions that help global enterprises—think big brands—manage customer and partner loyalty, engagement, and data. They help brands know you better so they can keep you coming back.

The current IPO is a significant event because it tests the Indian public market’s appetite for a company that has a global footprint (47 countries, 410+ brands) but a very new and modest profitability record.

Key IPO Snapshot: The Basic Facts

📊 Day 2 Scorecard: Subscription Status and GMP Capillary Technologies IPO Day 2

By the end of Day 1 and into the middle of Day 2, the IPO response has been moderate and cautious. This is the first signal investors should analyse.

1. Subscription Status (The Bidding Tally)

The subscription status tells us who is excited and who is waiting. (Data as of the morning of Day 2, Nov 17, 2025):

Also Read

Acetech E-Commerce IPO 2026 Price Band ₹106–₹112, Lot Size 1,200 Shares, Minimum Investment ₹1.27 Lakh & Full Details

Human Takeaway: A slow start isn’t always a death knell, especially for a QIB-heavy IPO (75% reserved for them). Institutional buyers often bid on the very last day after crunching all the numbers. However, the modest retail interest is a sign that the market isn’t enthusiastically chasing the stock yet.

2. The Grey Market Premium (GMP)

The GMP is the unofficial, speculative market’s pulse check. It’s the premium at which people are willing to buy and sell the unlisted shares in private markets.

• GMP Today (Day 2): $\mathbf{\sim₹24 – ₹25}$ per share.
• Implied Listing Price: $\text{₹577 (Issue Price)} + \text{₹24 (GMP)} = \mathbf{₹601}$
• Expected Listing Gain: $\mathbf{\sim4.2\%}$

Human Takeaway: The GMP is mild and fluctuating. It was reportedly higher earlier (up to ₹50) and then dipped, showing mixed signals.

• A gain of $\sim4.2\%$ suggests there is a small, modest listing gain on the cards, but nothing explosive.
• The fact that it’s low and volatile makes the IPO less attractive for purely “listing gain” investors. It suggests the primary focus should be on the company’s long-term value, not quick profits.

🧠 The Company DNA: Why Capillary Matters (and Why It’s Risky) Capillary Technologies IPO Day 2

To decide if you should apply, you need to understand Capillary’s business model and financials.

A. The Business: The SaaS Sweet Spot

Capillary is a company built for the digital age of customer relationship management (CRM). Their core strength lies in Loyalty Management and Customer Data Platforms (CDP).

Also Read

Realme 16 5G: The Ultimate Mid-Range Powerhouse Redefining Performance and Value

• What they do: They collect massive amounts of customer data, use AI to analyse it (e.g., predicting who is likely to leave), and then help brands run highly personalised loyalty programs, campaigns, and digital engagements.
• Key Strengths:
  1. Global Footprint: They serve over 410 brands in 47 countries, giving them a diversified revenue base outside India.
  2. High Customer Stickiness (NRR): Their Net Revenue Retention (NRR) rate is excellent ($\mathbf{>120\%}$). This means existing customers are not only staying but are spending $\mathbf{20\%}$ more with Capillary each year—a classic sign of a strong SaaS model.
  3. Profitability Turnaround: After years of losses (a typical journey for high-growth SaaS firms), they have turned profitable in FY25 (a profit of $\sim$₹14.15 crore) and maintained it in the first half of FY26 ($\sim$₹1.03 crore PAT). This is the biggest positive from a financial standpoint.

B. The Financial Elephant in the Room: Valuation

This is the single biggest point of contention for Capillary’s IPO and the reason for the cautious subscription.

• The Problem: The company is coming to market at an extremely aggressive valuation.
• The Numbers: Based on their recent small profit, the post-IPO Price-to-Earnings (P/E) ratio is estimated to be over $\mathbf{2,000x}$ to $\mathbf{2,200x}$!
  • Human Translation: A P/E of 2000x means investors are paying ₹2,000 for every ₹1 of profit the company made last year. This is not normal.
  • For context, their established global peers like Salesforce (a much larger, more established SaaS firm) trade at a P/E closer to $\mathbf{34x}$.
• The Justification: The high valuation is based on massive, projected future growth and the assumption that the company’s profitability will explode as its revenue scales (operating leverage). They are essentially asking you to pay today for profits they might make 5-7 years from now.

C. Other Critical Risks

• Revenue Concentration: Their top 10 customers contribute a significant portion of their revenue ($\sim56\%$). Losing even one or two big clients could severely impact the financials.
• Competition: They compete with global giants (like Salesforce, Adobe, Oracle, SAP) and highly focused loyalty platforms. It’s a hyper-competitive field.
• Customer Acquisition Cost (CAC): The cost to acquire new customers has been rising, which is a key metric to watch for a SaaS company.

🤔 The Million-Dollar Question: Should You Apply?

The decision to apply for Capillary Technologies IPO depends entirely on your goal and risk appetite. This is NOT an IPO for the faint of heart.

1. 🙅 AVOID if your goal is:

• Pure Listing Gains: The low GMP ( $\sim4.2\%$) does not justify the risk, particularly if the institutional bidding falls flat on the final day. There are usually better, safer bets for quick profits.
• Low Risk or Short-Term Investing: The aggressive valuation means that even a small piece of bad news (like missing a quarterly profit target) could cause a significant and sharp drop in the stock price after listing.

2. ✅ SUBSCRIBE for the Long Term if you are:

• A High-Risk, High-Reward Investor: You believe in the SaaS business model and the potential for Capillary to capture a large slice of the global loyalty market.
• An Investor with a 5- to 7-Year Horizon: You are willing to endure volatility, knowing you are betting on the company to successfully deliver on the massive growth priced into the $\mathbf{2,200x}$ valuation. You are willing to hold the stock for half a decade to realise the true value.

3. The Final Human Recommendation (The Cautious ‘Apply’):

Given the strong profitability turnaround (the most critical positive), the high NRR (proof of a sticky product), and the large commitment from Anchor Investors (who are the smartest money in the room, raising ₹394 crore before the IPO even opened), the stock has fundamental merit.

• What to do: If you have a moderate to high risk appetite and a long-term view, you may consider applying for one to two lots in the Retail Category.
• Wait for Day 3: Crucially, wait until the final day (November 18) to see the subscription status, especially the QIB portion. If the QIB portion sees significant oversubscription (more than 5x), it signals institutional confidence, and you can apply with more comfort. If QIB is still low, it’s a huge red flag.

🛑 Conclusion: A Bet on Future SaaS Supremacy

The Capillary Technologies India IPO is a pure play on the future of AI-driven Enterprise SaaS. It’s a story of a global-facing, technology-led company that has successfully achieved the crucial milestone of profitability after years of high-growth investment.

Also Read

Maruti YMC EV: भारत में सस्ती इलेक्ट्रिक SUV लॉन्च की तैयारी, जानें कीमत, फीचर्स और रेंज

The Price You Pay Today: You are paying for a future where Capillary is a much, much larger and more profitable company. The $\sim4.2\%$ GMP tells you there’s no immediate lottery win.

Your Investment Verdict: This is a selective subscription—only for investors who truly understand the dynamics of the SaaS sector, are comfortable with the extremely high valuation, and are prepared to hold for the long haul.

The safest strategy remains: Wait for the final hours of the subscription window on November 18 to see where the smart money (QIBs and NIIs) has landed. Their final vote will be your best indicator.

• Link to: “SaaS Companies to Watch in 2025“
• Link to: “How to Calculate Expected Listing Gains“

For additional content of this nature.: Mizulet